A cautious comeback for thalidomide.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000188:drug therapy; D019247:HIV Wasting Syndrome / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D012106:Research; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide